Cell and Gene Therapy Workflows Depend on More Than Manufacturing Alone

From collection to manufacturing and quality control, living cells remain sensitive to environmental conditions throughout the workflow.

Cell and gene therapy workflows increasingly operate across multiple sites, teams and processing steps. Starting material, intermediate products and analytical samples are often transferred between collection centers, manufacturing facilities, research laboratories and quality control environments before a therapy reaches the patient.

As these workflows become more distributed, transport conditions themselves become increasingly relevant.

Living cells remain biologically active throughout handling and transport. Temperature fluctuations, CO₂ loss, mechanical stress and prolonged exposure to non-physiological conditions can influence cellular behavior long before final analysis or application. In many workflows, viability alone is not the only relevant parameter. Functional integrity, consistency and reproducibility also matter.

This becomes particularly important in workflows involving sensitive primary cells, stem cells, immune cells or other function-dependent biological materials.

At the same time, modern CGT manufacturing environments continue to scale. Multi-site collaborations, centralized manufacturing models and international logistics increase the need for controlled and standardized transport processes between workflow steps.

Transport therefore becomes more than a logistical task. It becomes part of process consistency.

Maintaining stable environmental conditions during transport may help reduce pre-analytical variability and support more reliable downstream workflows, especially when biological material is transferred between laboratories, production sites or analytical environments.

For this reason, transport conditions are increasingly being discussed alongside topics such as chain of identity, manufacturing consistency and workflow standardization across the broader cell and gene therapy field.

Further insights into controlled live-cell transport workflows in CGT can be found here: